How big is the Australia In-vitro Diagnostics Market?

The Australia In-vitro Diagnostics Market size is expected to reach USD 1.86 billion in 2024 and grow at a CAGR of 5.36% to reach USD 2.41 billion by 2029. Read More

What is the current Australia In-vitro Diagnostics Market size?

In 2024, the Australia In-vitro Diagnostics Market size is expected to reach USD 1.86 billion. Read More

Who are the key players in Australia In-vitro Diagnostics Market?

Abbott, Bio-Rad Laboratories, Inc, BD, Roche Diagnostics and bioMérieux SA are the major companies operating in the Australia In-vitro Diagnostics Market. Read More

What years does this Australia In-vitro Diagnostics Market cover, and what was the market size in 2023?

In 2023, the Australia In-vitro Diagnostics Market size was estimated at USD 1.76 billion. The report covers the Australia In-vitro Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Australia In-vitro Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Australia In-vitro Diagnostics Companies

This report lists the top Australia In-vitro Diagnostics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Australia In-vitro Diagnostics industry.